Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Transfusion. 2018 Mar 9;58(5):1254–1263. doi: 10.1111/trf.14553

Figure 2.

Figure 2

Seroprevalence by age. Upper panel, anti-HEV IgG/total antibodies; lower panel, anti-HEV IgM. Solid line, DSI; dashed line MP Biomedicals; dotted line, Wantai. Data were plotted by averaging the seroprevalence by age range from donors 15 to 80 years of age in increments of 5 years, and all ages above 80 years of age formed the last range. Seroprevalence within each age range was plotted versus the mean age within the age range.